Raymond Debbane - 10 Oct 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Issuer symbol
LXRX
Transactions as of
10 Oct 2023
Net transactions value
+$1,103,957
Form type
4
Filing time
12 Oct 2023, 16:01:18 UTC
Previous filing
22 May 2023
Next filing
29 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $579,367 +508,306 +149% $1.14 849,153 10 Oct 2023 Direct F1
transaction LXRX Common Stock Purchase $370,784 +342,874 +40% $1.08 1,192,027 11 Oct 2023 Direct F2
transaction LXRX Common Stock Purchase $153,805 +148,820 +12% $1.03 1,340,847 12 Oct 2023 Direct F3
holding LXRX Common Stock 5,451,204 10 Oct 2023 By Invus US Partners LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.